Following trauma, feeling detached from one’s surroundings may suggest a higher risk of later developing psychiatric symptoms, according to research led by Harvard and McLean Hospital investigators, who are part of the NIH-funded AURORA Study led nationally by UNC’s Sam McLean, MD.

Genevieve Neal-Perry, MD, PhD, Distinguished Professor and Chair of Obstetrics and Gynecology, presented findings of this industry-sponsored study at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta.

Kenya McNeal-Trice, MD, Professor of Pediatrics and Vice Chair of Education in the UNC Department of Pediatrics, was recently selected to join the 2022-2023 AAMC Council of Deans Fellowship Program.

Led by Michelle Floris-Moore, MD, and Joe Eron, MD, this effort at UNC is one 11 infectious diseases divisions across the country selected for this pilot program launched by the Infectious Diseases Society of America with the CDC.

Cynthia Bulik, PhD, founding director of the UNC Center of Excellence for Eating Disorders, received the award from the Academy for Eating Disorders.

Tamara Baker, PhD, professor in the UNC Department of Psychiatry, has been named co-director of a new North Carolina Institute of Medicine Task Force on Healthy Aging funded through the Duke Endowment, the North Carolina Department of Health and Human Services, and AARP North Carolina.

James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health in the UNC School of Medicine, was lead investigator in the Phase 3 clinical trial of zilucoplan.

The NIH Office of Research Infrastructure Programs featured the lab of Fernando Pardo-Manuel de Villena, PhD, chair of the UNC Department of Genetics, for its crucial scientific contributions to improving research conducted with mouse models of human diseases.

Jenny Ting, PhD, in the UNC Department of Genetics, was among the 120 scientists elected to the prestigious National Academy of Sciences.

In the ultimate use of telemedicine, UNC School of Medicine’s Stephan Moll, MD, worked with NASA to treat a U.S. astronaut’s blood clot during a mission on the International Space Station. That led to a study on how blood flows in zero gravity, and if astronauts are at greater risk of developing blood clots in space.

James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

The UNC-Chapel Hill lab of Frank Conlon, PhD, and colleagues conducted experiments to show how a non-cardiac protein subunit interacts with three cardiac genes known to be mutated in patients with congenital heart disease.

Tag: Faculty

Feelings of Detachment Predict Worse Mental Outcomes After Trauma

Phase 3 Study Shows Fezolinetant Reduces Frequency, Severity of Menopausal Hot Flashes

McNeal-Trice Selected by AAMC for COD Fellowship Program

UNC Selected for Joint ID/CDC Epidemic Intelligence Service Fellowship Program

Bulik Receives Lifetime Achievement Honor for Pioneering Contributions in the Field of Eating Disorders

Baker Named Co-director of new NCIOM Task Force on Healthy Aging

UCB Presents Efficacy, Safety Results for Zilucoplan, Rozanolixizumab for Generalized Myasthenia Gravis

NIH Features Pardo-Manuel de Villena Lab

Ting Elected to National Academy of Sciences

UNC Blood Clot Expert Working with NASA to Study Blood Flow, Clot Formation in Zero Gravity

FDA Approves Treatment for Myasthenia Gravis After Phase III Study Led by James Howard, MD

Scientists Implicate Non-Cardiac Genes in Congenital Heart Disease